November 18, 2026 · Journal of oral and maxillofacial pathology : JOMFP · DOI: 10.4103/jomfp.jomfp_45_25

Fisetin induces G0/G1 arrest and apoptosis via mTOR signalling in HSC-3 cells.

Listen to this summary

Fisetin, a natural flavonoid, is evaluated for its ability to kill and halt the growth of HSC-3 oral carcinoma cells, with a focus on whether it acts through the mTOR signalling pathway. The authors measured dose-dependent cytotoxicity (MTT assay, IC50), changes in mTOR-related gene expression (e.g., 4EBP1, Glut1, PKM2, RAPTOR, S6K1, SGK1) by qRT-PCR, and fisetin's binding to mTOR pathway proteins via molecular docking. They report that fisetin reduces proliferation-associated gene expression, promotes apoptotic gene expression, and binds strongly to mTOR signalling proteins, suggesting it as a candidate for oral cancer therapy pending in vivo and clinical studies.

Selvaraj Jayaraman, Ramya Murali, Vishnu Priya Veeraraghavan

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play